Clinova – Product Pipeline Review – H2 2011 by GlobalMarketsDirect

VIEWS: 5 PAGES: 20

More Info
									Clinova – Product Pipeline Review




                Clinova – Product Pipeline Review – H2 2011


                                                                                              Reference Code: GMDHC02131CDB

                                                                                                   Publication Date: DEC 2011




Clinova – Product Pipeline Review – H2 2011
                                                                                          GMDHC02131CDB / Published DEC 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                 Page(1)
Clinova – Product Pipeline Review




Table of Contents
Table of Contents ............................................................................................................................................................................... 2
    List of Tables ................................................................................................................................................................................. 3
    List of Figures ................................................................................................................................................................................ 3
Clinova Snapshot ............................................................................................................................................................................... 4
    Clinova Overview........................................................................................................................................................................... 4
    Key Information ............................................................................................................................................................................. 4
    Key Facts....................................................................................................................................................................................... 4
Clinova – Research and Development Overview ............................................................................................................................... 5
    Key Therapeutic Areas .................................................................................................................................................................. 5
Clinova – Pipeline Review .................................................................................................................................................................. 7
    Pipeline Products by Stage of Development ................................................................................................................................. 7
    Pipeline Products – Monotherapy ................................................................................................................................................. 8
Clinova – Pipeline Products Glance ................................................................................................................................................... 9
    Clinova – Late Stage Pipeline........................................................................................................................................................ 9
         Phase III Products/Combination Treatment Modalities ............................................................................................................. 9
    Clinova – Early Stage Pipeline Products ..................................................................................................................................... 10
         Pre-Clinical Products/Combination Treatment Modalities ....................................................................................................... 10
Clinova – Drug Profiles ..................................................................................................................................................................... 11
    CLIN 3004 ................................................................................................................................................................................... 11
         Product Description................................................................................................................................................................. 11
         Mechanism of Action ............................................................................................................................................................... 11
         R&D Progress ......................................................................................................................................................................... 11
    CLIN 3007 ................................................................................................................................................................................... 12
         Product Description................................................................................................................................................................. 12
         Mechanism of Action ............................................................................................................................................................... 12
         R&D Progress ......................................................................................................................................................................... 12
    CLIN 3010 ................................................................................................................................................................................... 13
         Product Description................................................................................................................................................................. 13
         Mechanism of Action ............................................................................................................................................................... 13
         R&D Progress ......................................................................................................................................................................... 13
    CLIN 3011 ................................................................................................................................................................................... 14
         Product Description................................................................................................................................................................. 14
         Mechanism of Action ........
								
To top